Improved outcome of targeted delivery of chemotherapy drugs to the brain using a combined strategy of ultrasound, magnetic targeting and drug-loaded nanoparticles

Therapeutic Delivery

Volumn 2, Issue 2, 2011, Pages 137-141

  Deng, Cheri X ^a   Huang, Xuefei ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

blood brain barrier; brain tumor; cavitation; chemotherapy; drug delivery; magnetic nanoparticle; magnetic targeting; microbubble; MRI; ultrasound

Indexed keywords

EPIRUBICIN; FERUCARBOTRAN; MAGNETIC NANOPARTICLE; ANTINEOPLASTIC AGENT; NANOPARTICLE;

BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL MEMBRANE TRANSPORT; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG TISSUE LEVEL; ECHOGRAPHY; HUMAN; MEMBRANE DAMAGE; MICROBUBBLE; NEUROIMAGING; NONHUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARTICLE SIZE; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR VOLUME; ANIMAL; ARTICLE; BRAIN; MAGNETISM; METABOLISM; ULTRASOUND;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; BRAIN; HUMANS; MAGNETICS; MICROBUBBLES; NANOPARTICLES; ULTRASONICS;

EID: 79954457963     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.10.107     Document Type: Note

References (45)

1. Hynynen K, Mcdannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220(3), 640-646 (2001). (Pubitemid 32799969)
2. Hynynen K, Mcdannold N, Sheikov NA, Jolesz FA, Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24(1), 12-20 (2005). (Pubitemid 39611021)
3. Kinoshita M, Mcdannold N, Jolesz FA, Hynynen K. Noninvasive localized delivery of herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc. Natl Acad. Sci. USA 103(31), 11719-11723 (2006). (Pubitemid 44182517)
4. Kinoshita M, Mcdannold N, Jolesz FA, Hynynen K. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem. Biophys. Res. Commun. 340(4), 1085-1090 (2006). (Pubitemid 43083389)
5. Choi JJ, Wang S, Tung YS, Morrison B 3rd, Konofagou EE. Molecules of various pharmacologically-relevant sizes can cross the ultrasound-induced blood-brain barrier opening in vivo. Ultrasound Med. Biol. 36(1), 58-67 (2010).
6. Treat LH, Mcdannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int. J. Cancer 121(4), 901-907 (2007). (Pubitemid 47106223)
7. Hynynen K. Macromolecular delivery across the blood-brain barrier. Methods Mol. Biol. 480, 175-185 (2009).
8. Xie F, Boska MD, Lof J, Uberti MG, Tsutsui JM, Porter TR. Effects of transcranial ultrasound and intravenous microbubbles on blood-brain barrier permeability in a large animal model. Ultrasound Med. Biol. 34(12), 2028-2034 (2008).
9. Liu HL, Hua MY, Chen PY, et al. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255(2), 415-425 (2010).
10. Liu Y, Paliwal S, Bankiewicz KS, et al. Ultrasound-enhanced drug transport and distribution in the brain. AAPS PharmSciTech 11(3), 1005-1017 (2010).
11. Mcdannold N, Clement GT, Black P, Jolesz F, Hynynen K Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurgery 66(2), 323-332 (2010).
12. Liu HL, Hua MY, Yang HW, et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc. Natl Acad. Sci. USA 107(34), 15205-15210 (2010).
13. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94(10), 2698-2705 (2002). (Pubitemid 34478086)
14. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2(1), 3-14 (2005). (Pubitemid 40128022)
15. Tosoni A, Ermani M, Brandes AA. The pathogenesis and treatment of brain metastases: a comprehensive review. Crit. Rev. Oncol. Hematol. 52(3), 199-215 (2004). (Pubitemid 39593754)
16. Pardridge WM. Drug and gene delivery to the brain: the vascular route. Neuron 36(4), 555-558 (2002). (Pubitemid 35346750)
17. Cecchelli R, Berezowski V, Lundquist S, et al. Modelling of the blood-brain barrier in drug discovery and development. Nat. Rev. Drug Discov. 6(8), 650-661 (2007). (Pubitemid 47202487)
18. Juillerat-Jeanneret L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov. Today 13(23-24), 1099-1106 (2008).
19. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol. Dis. 37(1), 13-25 (2010).
20. Pardridge WM. Blood-brain barrier delivery. Drug Discov. Today 12(1-2), 54-61 (2007). (Pubitemid 46014479)
21. Pardridge WM. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Bioconjug. Chem. 19(7), 1327-1338 (2008). (Pubitemid 352032329)
22. Jahnke K, Kraemer DF, Knight KR, et al. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system. Cancer 112(3), 581-588 (2008). (Pubitemid 351186198)
23. Doolittle ND, Abrey LE, Bleyer WA, et al. New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual blood-brain barrier disruption consortium meeting. Clin. Cancer Res. 11(2 Pt 1), 421-428 (2005). (Pubitemid 40116864)
24. Vogelbaum MA. Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review. J. Neurooncol. 83(1), 97-109 (2007). (Pubitemid 46647172)
25. Bidros DS, Liu JK, Vogelbaum MA. Future of convection-enhanced delivery in the treatment of brain tumors. Future Oncol. 6(1), 117-125 (2010).
26. Mcdannold N, Vykhodtseva N, Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys. Med. Biol. 51(4), 793-807 (2006).
27. Hynynen K, Clement GT, Mcdannold N, et al. 500-element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls. Magn. Reson. Med. 52(1), 100-107 (2004). (Pubitemid 39295261)
28. Choi JJ, Pernot M, Small AS, Konofagou EE. Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice. Ultrasound Med. Biol. 33(1), 95-104 (2007). (Pubitemid 44959316)
29. Marquet F, Pernot M, Aubry JF, et al. Non-invasive transcranial ultrasound therapy based on a 3D CT scan: protocol validation and in vitro results. Phys. Med. Biol. 54(9), 2597-2613 (2009).
30. Deng CX. Targeted drug delivery across the blood-brain barrier using ultrasound technique. Ther. Deliv. 1(6) 819-848 (2010).
31. Mcdannold N, Vykhodtseva N, Hynynen K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound Med. Biol. 34(6), 930-937 (2008). (Pubitemid 351697595)
32. Tu J, Hwang JH, Matula TJ, Brayman AA, Crum LA. Intravascular inertial cavitation activity detection and quantification in vivo with optison. Ultrasound Med. Biol. 32(10), 1601-1609 (2006). (Pubitemid 44528118)
33. Price RJ, Skyba DM, Kaul S, Skalak TC. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 98(13), 1264-1267 (1998). (Pubitemid 28443388)
34. Wu J. Shear stress in cells generated by ultrasound. Prog. Biophys. Mol. Biol. 93(1-3), 363-373 (2007). (Pubitemid 44809397)
35. Vanbavel E. Effects of shear stress on endothelial cells: possible relevance for ultrasound applications. Prog. Biophys. Mol. Biol. 93(1-3), 374-383 (2007).
36. Marmottant P, Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 423(6936), 153-156 (2003). (Pubitemid 36569534)
37. Van Wamel A, Kooiman K, Harteveld M, et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J. Control. Release 112(2), 149-155 (2006).
38. Collis J, Manasseh R, Liovic P, et al. Cavitation microstreaming and stress fields created by microbubbles. Ultrasonics 50(2), 273-279 (2010).
39. Pecha R, Gompf B. Microimplosions: cavitation collapse and shock wave emission on a nanosecond time scale. Phys. Rev. Lett. 84(6), 1328-1330 (2000).
40. Ohl CD, Arora M, Ikink R, et al. Sonoporation from jetting cavitation bubbles. Biophys. J. 91(11), 4285-4295 (2006). (Pubitemid 44887286)
41. Sheikov N, Mcdannold N, Sharma S, Hynynen K. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med. Biol. 34(7), 1093-1104 (2008). (Pubitemid 351893156)
42. Sheikov N, Mcdannold N, Vykhodtseva N, Jolesz F, Hynynen K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med. Biol. 30(7), 979-989 (2004). (Pubitemid 39094314)
43. Jong A, Huang SH. Blood-brain barrier drug discovery for central nervous system infections. Curr. Drug Targets Infect. Disord. 5(1), 65-72 (2005). (Pubitemid 40467701)
44. Sugimoto H, Hirabayashi H, Kimura Y, Furuta A, Amano N, Moriwaki T. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats. Drug Metab. Dispos. 39(1), 8-14 (2011)
45. Deng CX. Sonoporation and gene delivery. In: Therapeutic Ultrasound: Mechanisms to Applications. Frenkel V (Ed.). Nova Science Publishers, NY, USA (2010).